350.40
+5.05%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Suraksha Diagnostic
Its shares trade on NSE under the ticker SURAKSHA.NS. It has been listed since 6 December 2024. In the fiscal year to 31 March 2026, it reported revenue of ₹3.10bn and net income of ₹321.9m. At that date it held total assets of ₹4.48bn and shareholders' equity of ₹2.45bn.
Suraksha Diagnostic Ltd is a IN-based company operating in industry. The company is headquartered in Kolkata, West Bengal. The company went IPO on 2024-12-06. Suraksha Diagnostic Limited is an India-based company. The firm is primarily engaged in the business of running diagnostic centers for carrying out various pathological and radiological services. The firm offers integrated solutions for pathology and radiology testing, and medical consultation services to its customers through its operational network. Its services include Imaging, Neurology, Cardiology, Gastroenterology, and Pathology. Its Imaging services include X-Ray, DEXA scan, USG scan, CT scan and others. Its Neurology services include EEG, EMG, NCV. Its Cardiology services include Echocardiogram Test, Stress Test / Treadmill Test, Holter Monitoring, Color Doppler, Peripheral Doppler, and others. Its Pathology services include Microbiology, Cytogenetic, Serology, Molecular Biology, Histopathology, Cytopathology, Haematology, and others. Its Gastroenterology services include Upper GI Endoscopy, Sigmoidoscopy, Colonoscopy, Proctoscopy, Proctosigmoidoscopy, and others.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 6 Dec 2024
- Employees
- 1,173
- Website
- surakshanet.com ↗
Leadership
Pay as last reported
- Dr. Somnath ChatterjeeExecutive Chairman of the Board and Joint Managing Director, since 2005₹21.6m
- Ms. Ritu MittalJoint Managing Director and Chief Executive Officer, Executive Director, since 2006₹21.6m
- Mr. K S RavindraChief Financial Officer
- Ms. Mamta JainCompany Secretary and Compliance Officer
- Mr. Satish VermaNon-Executive Non-Independent Director
- Mr. Pradip DuttaNon-Executive Independent Director₹545,000
- Mr. Dharam DharewaNon-Executive Independent Director₹365,000
- Ms. Ishani RayNon-Executive Independent Director₹625,000
- Mr. Siddhartha RoyNon-Executive Independent Director₹285,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Suraksha Diagnostic Ltd operates 1173 employees in Kolkata, West Bengal for pathology and radiology services.
- The company offers integrated solutions including Imaging, Neurology, Cardiology, Gastroenterology, and Pathology services.
- Suraksha Diagnostic Limited provides comprehensive medical consultation through its operational network in India.
Weaknesses
- The company's IPO listing date is 6 December 2024, which may affect early market performance.
- Suraksha Diagnostic Ltd is headquartered in Kolkata, West Bengal, limiting regional expansion potential.
- The firm's focus on diagnostic centers may restrict diversification into other healthcare sectors.
Opportunities
- Expanding Imaging services to include X-Ray, DEXA scan, and CT scan across India.
- Growing demand for Neurology services such as EEG and EMG in urban centers.
- Increasing Pathology services like Microbiology and Histopathology in metropolitan areas.
Threats
- Competition from established diagnostic centers in Kolkata and West Bengal.
- Regulatory changes in the Indian healthcare sector affecting diagnostic services.
- Economic downturns impacting patient affordability for non-essential medical tests.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.